| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/23/2008 | CN100362997C Enteric coated table of duloxetine, and preparation method |
| 01/23/2008 | CN100362996C Duloxetine enteric coated tiny pill capsule, and preparation method |
| 01/23/2008 | CN100362995C CYP2A enzymes and their use in therapeutic and diagnostic method |
| 01/22/2008 | US7320994 {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1H-[1,2,3]triazol-4-yl]-pyridin-3-yl}-(2-chloro-phenyl)-methanone; anxiety, depression, psychosis, and schizophrenia and other psychotic disorders; neurodegenerative disorders, multiple sclerosis and amyotrophic lateral sclerosis |
| 01/22/2008 | US7320980 Substituted pyrido(1,2-a)pyrimidines and their use as NOS inhibitors |
| 01/22/2008 | US7320969 Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
| 01/22/2008 | US7320964 Modulation of expression of STAT-1 dependent genes |
| 01/22/2008 | US7320872 Genetically engineered nervous system cells for use in the treatment of alzheimer's, parkinson's, amyotrophic lateral sclerosis, multiple sclerosis, trauma, brain, muscle, cardiovascular, vision , liver, kidney and pancreas disorders |
| 01/22/2008 | US7320793 Comprises ordered and repetitive antigen or antigenic determinant array for developing vaccines for treatment of infectious diseases, allergies and cancer; microarrays |
| 01/22/2008 | US7320785 Compositions and methods for modulation of DARPP-32 phosphorylation |
| 01/22/2008 | US7320784 Metal support surface, conjugate releasably bound to the support surface, the conjugate comprising a ligand and a targeting molecule;wherein the conjugate coordinates with a complex-forming metal ion so that labeled conjugate is released; radiotherapy and as imaging agents in medical diagnostics |
| 01/22/2008 | CA2495967C New synthesis process and new crystalline form for agomelatine, and pharmaceutical compositions containing it |
| 01/22/2008 | CA2490638C Combination therapy wherein a serotonin reuptake inhibitor is used |
| 01/22/2008 | CA2392168C Vitamin d analogues |
| 01/22/2008 | CA2382577C Injectable buprenorphine microparticle compositions and their use |
| 01/22/2008 | CA2368348C Biodegradable, injectable oligomer-polymer composition |
| 01/22/2008 | CA2333322C Nitric oxide synthase inhibitors |
| 01/22/2008 | CA2309629C Aqueous suspensions of submicron 9-hydroxyrisperidone fatty acid esters |
| 01/22/2008 | CA2300405C Use of cholinesterase inhibitors for treating attention deficit disorders |
| 01/22/2008 | CA2222676C New pharmaceutical composition with anaesthetic effect |
| 01/22/2008 | CA2195419C Immunological activity of rhamnolipids |
| 01/17/2008 | WO2008008821A2 Use of trifluoromethyl substituted benzamides in the treatment of neurological disorders |
| 01/17/2008 | WO2008008553A2 Genetic polymorphisms associated with alzheimer's disease, methods of detection and uses thereof |
| 01/17/2008 | WO2008008518A1 Substituted diazepan orexin receptor antagonists |
| 01/17/2008 | WO2008008442A1 Preparation and utility of hmg-coa reductase inhibitors |
| 01/17/2008 | WO2008008273A1 Polymorphic form of fluoro-7-(2,2,2-trifluoroethoxy) phenoxathiin-10,10-dioxide |
| 01/17/2008 | WO2008008114A2 Use of adipose-derived stem cells for treatment of leukodystrophies |
| 01/17/2008 | WO2008008020A1 3-oxoisoindoline-1-carboxamide derivatives as analgesic agents |
| 01/17/2008 | WO2008007835A1 2,4-quinazoline derivatives having activity to t-type calcium channel and preparation method thereof |
| 01/17/2008 | WO2008007780A1 Pentadienamide derivative |
| 01/17/2008 | WO2008007766A1 Crystal of benzoxadiazole derivative |
| 01/17/2008 | WO2008007691A1 Salt of morpholine compound |
| 01/17/2008 | WO2008007554A1 Adhesive preparation |
| 01/17/2008 | WO2008007426A1 Analgesic agent |
| 01/17/2008 | WO2008007211A1 Substituted n-bicyclicalkyl bicyclic carboxyamide compounds |
| 01/17/2008 | WO2008007163A1 Peganine isolated from anisotes trisulcus l. as a smoking deterrent and anorxigenic agent |
| 01/17/2008 | WO2008007149A2 New medical use of triazine derivatives |
| 01/17/2008 | WO2008007131A2 Treatment for demyelinating disease |
| 01/17/2008 | WO2008007117A1 Pharmaceutically acceptable salt and polymorphic forms of flupirtine maleate |
| 01/17/2008 | WO2008006979A2 Process for preparing diaminophenothiazinium compounds |
| 01/17/2008 | WO2008006918A1 Use of flumazenil in the production of a medicament for the treatment of depressive disorders |
| 01/17/2008 | WO2008006795A2 Indole compounds |
| 01/17/2008 | WO2008006790A1 Indole compounds |
| 01/17/2008 | WO2008006372A1 (3-aryl-piperazin-1-yl), (2-aryl-morpholin-4-yl) and (2-aryl- thiomorpholin-4-yl) derivatives of 6,7-dialkoxyquinazoline, 6,7- dialkoxyphtalazine and 6,7-dialkoxyisoquinoline |
| 01/17/2008 | WO2008006286A1 ANALGESIC 5, 9 - METHANOCYCLOOCTA (b) PYRIDIN - 2 (1H) - ONE DERIVATIVES, THEIR PREPARATION METHOD AND USE |
| 01/17/2008 | WO2008006276A1 THE SMALL MOLECULE INHIBITOR WHICH CAN INHIBIT THE AβPOLYPEPTIDE FIBROSIS OF ALZHEIMER'S DISEASE, THEIR PREPAREATION METHODS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF |
| 01/17/2008 | WO2007137164A3 Co-therapy for the treatment of epilepsy and related disorders |
| 01/17/2008 | WO2007136743A3 Dothiepin and methods of using the same to treat sleep disorders |
| 01/17/2008 | WO2007135406A3 New forms of active pharmaceutical ingredient |
| 01/17/2008 | WO2007131020A3 Constrained compounds as cgrp-receptor antagonists |
| 01/17/2008 | WO2007120925A3 Crystal forms of o-desmethylvenlafaxine |
| 01/17/2008 | WO2007117577A3 High affinity human antibodies to human il-18 receptor |
| 01/17/2008 | WO2007112000A3 Treatment of pain |
| 01/17/2008 | WO2007081907A3 Crystalline forms of dolasetron base and processes for preparation thereof |
| 01/17/2008 | WO2007075297A3 Muscarinic agonists and methods of use thereof |
| 01/17/2008 | WO2007063428A3 Pharmaceutical compositions comprising carboxyalkylsulfonic acids |
| 01/17/2008 | WO2007056300A3 Methods and compositions for the treatment of brain reward system disorders by combination therapy |
| 01/17/2008 | WO2007019080A3 Tricyclic beta-secretase inhibitors for the treatment of alzheimer's disease |
| 01/17/2008 | WO2006137789A8 Quinoline 3 -sulfonate esters as NK3 receptor modulators |
| 01/17/2008 | WO2004106938A3 Diagnostics and therapeutics for diseases associated with g protein-coupled p2y purinoreceptor 7 (p2y7) |
| 01/17/2008 | WO2004106935A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 103 (gpr103) |
| 01/17/2008 | WO2003004615A3 Secreted proteins |
| 01/17/2008 | US20080015256 Tetralin and indane derivatives and uses thereof |
| 01/17/2008 | US20080015242 Use of N-[3-[2-[2-(3-methylindazol-6-yloxy)ethylamino]-1-hydroxyethyl]phenyl]methanesulfonamide or salt for treating diabetes, obesity, hyperlipidemia and urinary incontinence; drug interaction side effect reduction |
| 01/17/2008 | US20080015235 Histamine H3 Receptor Inhibitors, Preparation and Therapeutic Uses |
| 01/17/2008 | US20080015234 Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 01/17/2008 | US20080015233 2,4,6-Substituted Pyridyl Derivative Compounds Useful as Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease |
| 01/17/2008 | US20080015225 Dimeric Piperidine Derivatives |
| 01/17/2008 | US20080015223 Pyrazole Derivatives as Modulators of the 5-Ht2a Serotonin Receptor Useful for the Treatment of Disorders Related Thereto |
| 01/17/2008 | US20080015214 3-piperidin-4-yl-indole orl-1 receptor modulators |
| 01/17/2008 | US20080015213 Macrocyclic Aminopyridyl Beta-Secretase Inhibitors For The Treatment Of Alzheimer's Disease |
| 01/17/2008 | US20080015209 Compounds for the treatment of metabolic disorders |
| 01/17/2008 | US20080015208 3-Fluoro-N-(5-ureidomethyl-5,6,7,8-tetrahydro-naphthalen-2-yl)-benzenesulfonamide; serotonin receptors 5-HT6 and 5-HT2A ligand; neurodegenerative disorders; antidepressant, anxiolytic agent; Parkinson's disease, Huntington's disease, manic depression, psychoses, epilepsy, obesity, drug abuse |
| 01/17/2008 | US20080015204 Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 01/17/2008 | US20080015201 3-(Phenylsulfonyl)-7-piperazin-1-yl-1H-pyrazolo[4,3-b]pyridine; 5-HT receptor subtype 5HT6; selective serotonin receptor antagonist; cognition actiators; alzheimer's disease; attention deficit disorder; antidepressant; antiepileptic agent; anxiolytic agents; obsessive compulsive disorder; Parkinson's |
| 01/17/2008 | US20080015197 Process for the preparatrion of zopiclone |
| 01/17/2008 | US20080015193 Certain azoles exhibiting ATP-utilizing enzyme inhibitory activity, compositions, and uses thereof |
| 01/17/2008 | US20080015190 Inhibitors of Histone Deacetylase |
| 01/17/2008 | US20080015185 N-heterocyclic inhibitors of tnf-alpha expression |
| 01/17/2008 | US20080015183 Substituted quinazolin-4-ylamine analogues |
| 01/17/2008 | US20080015180 Methods and compositions for treating amyloid-related diseases |
| 01/17/2008 | US20080015179 such as ethyl 3-(1'-methyl-2'-oxospiro[cyclohexane-1,3'-indoline]-4-yl)-8-azabicyclo[3.2.1]octane-8-carboxylate, used for the treatment of nervous system disorders, psychological disorders, autoimmune diseases, gastrointestinal disorders, vision defects, obesity and cardiovascular disorders |
| 01/17/2008 | US20080015175 Nontoxic; inhibition of interleukin-1 beta -converting enzyme |
| 01/17/2008 | US20080015173 Estrogen Receptor Modulators |
| 01/17/2008 | US20080015172 Caspase inhibitors and uses thereof |
| 01/17/2008 | US20080015169 Amino-methyl substituted tetracycline compounds |
| 01/17/2008 | US20080015158 By using a double-stranded RNA (dsRNA); neurodegenerative disorder |
| 01/17/2008 | US20080015152 Therapeutic amino acid sequences for use in treatment and prevention of viral, infectious, cancerous, diabetic, incontinent, hypertensive, eating and nervous system disorders |
| 01/17/2008 | US20080015147 Method for inhibiting neuronal cell death |
| 01/17/2008 | US20080015146 e.g. 3-Amino-1-[(S)-2-(3-tert-butyl-[1,2,4]oxadiazol-5-yl)-pyrrolidin-1-yl]-4-(2,4,5-trifluorophenyl)-butan-1-one; dipeptidyl-peptidase inhibitor; antidiabetic, hypoglycemic agent; metabolic disorders, obesity, non-insulin dependent diabetes |
| 01/17/2008 | US20080014585 Synergistic activation of regulatory elements by rel proteins and a steroid receptor |
| 01/17/2008 | US20080014271 Novel pharmaceutical compositions comprising levetiracetam |
| 01/17/2008 | US20080014269 Oxacarbazepine film-coated tablets |
| 01/17/2008 | US20080014264 Novel pharmaceutical compositions comprising levetiracetam |
| 01/17/2008 | US20080014262 Rapidly disintegrating tablet containing polyvinyl alcohol |
| 01/17/2008 | US20080014259 Compositions of R(+) and S(-) Pramipexole and Methods of Using the Same |
| 01/17/2008 | US20080014252 Topical compositions with long lasting effect |
| 01/17/2008 | US20080014250 Bifunctionalized polysaccharides |
| 01/17/2008 | US20080014249 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 01/17/2008 | US20080014228 Solid form |